Importantly, our findings provide insights into the role of the frequently mutated TP53 locus in SCLC, particularly since point mutations in p53 are associated with sensitivity to chemotherapy treatment26,27 and similar gain-of-function mutations have been documented in other cancer types46,47. This evidence concerns the gene TP53 and small cell lung carcinoma.